Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1281-1290

  Wang, Xiujuan ^a   Gong, Yanbing ^a   Jin, Bo ^a   Wu, Chenglin ^a   Yang, Jianming ^a   Wang, Le ^a   Zhang, Zheng ^b   Mao, Zebin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

BRG1; lncRNA; UCA1

Indexed keywords

BRG1 PROTEIN; LONG UNTRANSLATED RNA; ONCOPROTEIN; PROTEIN P21; UNCLASSIFIED DRUG; UROTHELIAL CARCINOMA ASSOCIATED 1 PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA HELICASE; NUCLEAR PROTEIN; SMARCA4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UCA1 RNA, HUMAN;

5637 CANCER CELL; ARTICLE; ASSAY; BLADDER CANCER; BRG1 GENE; CANCER CELL LINE; CANCER INHIBITION; CELL DIVISION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; PULL DOWN ASSAY; RNA INTERFERENCE; SEQUENCE ANALYSIS; TRANSITIONAL CELL CARCINOMA; UCA1 GENE; UPREGULATION; BLADDER TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; RNA, LONG NONCODING; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84923068536     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3309     Document Type: Article

References (30)

1. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, et al: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816, 2007.
2. Khachane AN and Harrison PM: Mining mammalian transcript data for functional long non-coding RNAs. PLoS One 5: e10316, 2010.
3. Tsang WP, Wong TW, Cheung AH, Co CN and Kwok TT: Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA 13: 890-898, 2007. (Pubitemid 46799823)
4. Wilusz JE, Sunwoo H and Spector DL: Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23: 1494-1504, 2009.
5. Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914, 2011.
6. Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159, 2009.
7. Costa FF: Non-coding RNAs, epigenetics and complexity. Gene 410: 9-17, 2008.
8. Faghihi MA and Wahlestedt C: Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10: 637-643, 2009.
9. Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell 136: 629-641, 2009.
10. Gibb EA, Brown CJ and Lam WL: The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38, 2011.
11. Wapinski O and Chang HY: Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361, 2011.
12. Wang XS, Zhang Z, Wang HC, et al: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12: 4851-4858, 2006. (Pubitemid 44338570)
13. Xie XJ, Li X, Wang F and Chen W: Cellular localization and tissue expression pattern of UCA1, a non-coding RNA. Nan Fang Yi Ke Da Xue Xue Bao 30: 57-60, 2010 (In Chinese).
14. Wang F, Li X, Xie X, Zhao L and Chen W: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582: 1919-1927, 2008.
15. Peifer M and Polakis P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609, 2000. (Pubitemid 30127755)
16. Shimada T and Fujii-Kuriyama Y: Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95: 1-6, 2004. (Pubitemid 38208399)
17. Katayama H, Brinkley WR and Sen S: The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22: 451-464, 2003. (Pubitemid 36791899)
18. Wilson BG and Roberts CW: SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492, 2011.
19. Kidder BL, Palmer S and Knott JG: SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 27: 317-328, 2009.
20. Tu Z, Zhuang X, Yao YG and Zhang R: BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol 33: 1819-1829, 2013.
21. Kang H, Cui K and Zhao K: BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol 24: 1188-1199, 2004. (Pubitemid 38112181)
22. Xu Y, Zhang J and Chen X: The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem 282: 37429-37435, 2007.
23. Tsai MC, Manor O, Wan Y, et al: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693, 2010.
24. Bochar DA, Savard J, Wang W, et al: A family of chromatin remodeling factors related to Williams syndrome transcription factor. Proc Natl Acad Sci USA 97: 1038-1043, 2000. (Pubitemid 30080808)
25. Yang C, Li X, Wang Y, Zhao L and Chen W: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496: 8-16, 2012.
26. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M and Clevers H: The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO J 20: 4935-4943, 2001. (Pubitemid 32848645)
27. DiRenzo J, Shang YF, Phelan M, et al: BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20: 7541-7549, 2000.
28. Alessio N, Squillaro T, Cipollaro M, Bagella L, Giordano A and Galderisi U: The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 29: 5452-5463, 2010.
29. Aravinthan A, Mells G, Allison M, et al: Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. Cell Cycle 13: 1489-1494, 2014.
30. Bai J, Chen J, Ma M, et al: Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16. DNA Cell Biol 33: 337-344, 2014.